The insulin activity model based on insulin profiles
Abstract
The purpose of the research was to propound an insulin activity model in a human body after a subcutaneous injection. A deterministic model in the form of a mathematical function was formulated. The research was based on pharmaceutic publicly available drug information published by the manufactures. The paper presents in detail the model. The obtained results can be used in computer simulations of diabetes mellitus therapy. They suggest that activity models may be assigned to types of insulin instead of separate products.
Keywords:
insulin profiles; insulin activity; diabetes mellitus; computer therapyReferences
[1] OPENAPS.ORG, https://openaps.org, [05.11.2019]
[2] Global Human Insulin Drugs Market - Growth, Trends and Forecast (2019 – 2024), Mordor Intelligence, https://www.mordorintelligence.com/industry-reports/insulin-market, [05.11.2019]
[3] Fiasp : EPAR – Product Information, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/fiasp, update 30/10/2019, [05.11.2019]
[4] NovoRapid: Product Monograph, Novo Nordisk Canada Inc., www.novonordisk.ca/our-products.html, [28.10.2019]
[5] Actrapid : EPAR – Scientific Discussion, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/actrapid, update 03/04/2006, [05.11.2019]
[6] Apidra Product Monograph, Sanofi-Aventis Canada Inc., version 14.0 dated October 17 2017, http://products.sanofi.ca/en/apidra.pdf, [05.11.2019]
[7] Insuman : EPAR – Product Information, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/insuman, update 21/05/2019, [05.11.2019]
[8] Humalog Product Monograph, ELI LILLY CANADA INC., November 28, 2017, http://pi.lilly.com/ca/humalog-ca-pm.pdf, [05.11.2019]
[2] Global Human Insulin Drugs Market - Growth, Trends and Forecast (2019 – 2024), Mordor Intelligence, https://www.mordorintelligence.com/industry-reports/insulin-market, [05.11.2019]
[3] Fiasp : EPAR – Product Information, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/fiasp, update 30/10/2019, [05.11.2019]
[4] NovoRapid: Product Monograph, Novo Nordisk Canada Inc., www.novonordisk.ca/our-products.html, [28.10.2019]
[5] Actrapid : EPAR – Scientific Discussion, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/actrapid, update 03/04/2006, [05.11.2019]
[6] Apidra Product Monograph, Sanofi-Aventis Canada Inc., version 14.0 dated October 17 2017, http://products.sanofi.ca/en/apidra.pdf, [05.11.2019]
[7] Insuman : EPAR – Product Information, European Medicines Agency, www.ema.europa.eu/en/medicines/human/EPAR/insuman, update 21/05/2019, [05.11.2019]
[8] Humalog Product Monograph, ELI LILLY CANADA INC., November 28, 2017, http://pi.lilly.com/ca/humalog-ca-pm.pdf, [05.11.2019]
Nowicki, T. (2019). The insulin activity model based on insulin profiles. Journal of Computer Sciences Institute, 13, 272–278. https://doi.org/10.35784/jcsi.1294
Statistics
Abstract views: 349PDF downloads: 234
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
